Other Vaccines - Ghana

Ghana

Highlights

In Ghana, the revenue in the Other Vaccines market is projected to reach US$9.62m in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 10.52%, resulting in a market volume of US$15.86m by 2029.
When compared globally, United States is expected to generate the highest revenue of US$24.73bn in 2024.
Ghana's increasing demand for other vaccines is driven by a growing awareness of the importance of preventive healthcare.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The demand for Other Vaccines in Ghana has been on the rise in recent years.

Customer preferences: Ghanaians have become more aware of the importance of vaccination, which has led to an increase in demand for Other Vaccines. The government has also been actively promoting vaccination campaigns across the country, which has further boosted the demand for Other Vaccines.

Trends in the market: The Other Vaccines market in Ghana has been growing steadily over the past few years. This growth can be attributed to the increasing awareness about the importance of vaccination and the government's efforts to promote vaccination campaigns. Additionally, the rise in the number of infectious diseases in the country has also led to an increase in demand for Other Vaccines.

Local special circumstances: Ghana has a high incidence of infectious diseases, which has led to a higher demand for vaccines. Additionally, the country has a large population, which has further increased the demand for Other Vaccines. The government has also been working to improve the healthcare system in the country, which has led to an increase in the availability of vaccines.

Underlying macroeconomic factors: Ghana's economy has been growing steadily over the past few years, which has led to an increase in disposable income. This has made it easier for people to afford vaccines, which has further boosted the demand for Other Vaccines. Additionally, the government's efforts to improve the healthcare system have also contributed to the growth of the Other Vaccines market in Ghana.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.